Browsing articles in "Bipolar Disorders"


Blood Test to Diagnose Bipolar Disorder
November 16, 2023   

A recent study aimed to differentiate bipolar disorder from major depressive disorder using metabolomic profiling of dried blood spots...
 Continue reading (Members only)
Screening for Eating Disorders in Patients with Bipolar Disorder
September 25, 2023   

Bipolar disorder is a prevalent and debilitating psychiatric condition frequently co-occurring with other disorders, including eating disorders. A recent study aimed to explore the prevalence and clinical associations of eating disorders in individuals with bipolar disorders, ...
 Continue reading
Brain Volume Patterns Vary Across Psychiatric Disorders
September 5, 2023   

Differential diagnosis of, and perhaps development of effective treatments for, psychiatric conditions would certainly be easier if we had reliable biomarkers such as neuroimaging. Unfortunately, such biomarkers do not currently exist; in the treasure hunt for a neuroimaging biomarker for a specific psychiatric illness, there is no..
 Continue reading (Members only)
Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression
August 24, 2023   

Antidepressants are commonly prescribed to treat acute depressive episodes in bipolar disorder, but their role as maintenance therapy has not been extensively studied. A recent paper published in the New England Journal sought to examine the efficacy of antidepressants as maintenance treatment after the remission of depression...
 Continue reading (Members only)
FDA Approves Aripiprazole as First Once-Every-2-Months Long-Acting Injectable for Schizophrenia, Bipolar I Disorder
April 27, 2023   

The U.S. Food and Drug Administration has approved a new drug application for a once-every-two-months long-acting injectable version of aripiprazole for the treatment of schizophrenia in adults or for maintenance monotherapy treatment of bipolar I disorder in adults...
 Continue reading
High Dose Antipsychotic Polypharmacy and Hospitalization Risk
April 13, 2023   

Historically, practice guidelines have recommended antipsychotic monotherapy over polypharmacy -partially due to concerns over the safety of utilizing two antipsychotics at the same time. A recent study compared antipsychotic monotherapy with antipsychotic polypharmacy in terms of safety (specifically nonpsychiatric hospitalization and hospitalization for cardiovascular reasons) and risk of relapse (as indicated by psychiatric hospitalization) at various defined daily doses...
 Continue reading (Members only)
2023 NEI Synapse: Distinguishing Between and Treating BPI and BPII
March 31, 2023   

Bipolar disorders are associated with polymorbidity and a higher risk of suicide than the general population. Thus, their prompt diagnosis and treatment are essential to maximize patient outcomes...
 Continue reading
World Bipolar Day Is Celebrated Each Year On March 30th
March 26, 2023   

World Bipolar Day is celebrated each year on March 30th. World Bipolar Day's ultimate goal is to inspire a global shift in thinking that will eliminate social stigma and promote acceptance...
 Continue reading
Bright Light Therapy Boosts Therapeutic Response in Bipolar Depression
March 16, 2023   

For over three decades bright light therapy has been used to treat seasonal affective disorder, unipolar depression, and bipolar depression, with a growing body of literature to support its efficacy. A recent study sought to determine if bright light therapy accelerated and increased the therapeutic response to antidepressants after 4 and 8 weeks of treatment in patients with bipolar depression. ..
 Continue reading
The Future of Psychopharmacology
February 9, 2023   

It is an incredible time in terms of the development of new psychopharmacological agents with novel mechanisms of action. In this article, leading experts in the field of psychopharmacology discuss the most promising medications in Phase II and III clinical trials that are being investigated for schizophrenia, bipolar disorder, major depressive disorder, anxiety, substance use disorders, and dementia...
 Continue reading (Members only)
Top of Page